BRPI0911552A2 - métodos para determinar a presença de um analito de interesse, de uma pluralidade de analitos de interesse diferentes, e de pelo menos um membro de uma classe de drogas de interesse. - Google Patents

métodos para determinar a presença de um analito de interesse, de uma pluralidade de analitos de interesse diferentes, e de pelo menos um membro de uma classe de drogas de interesse.

Info

Publication number
BRPI0911552A2
BRPI0911552A2 BRPI0911552-8A BRPI0911552A BRPI0911552A2 BR PI0911552 A2 BRPI0911552 A2 BR PI0911552A2 BR PI0911552 A BRPI0911552 A BR PI0911552A BR PI0911552 A2 BRPI0911552 A2 BR PI0911552A2
Authority
BR
Brazil
Prior art keywords
interest
methods
analytes
analyte
determining
Prior art date
Application number
BRPI0911552-8A
Other languages
English (en)
Inventor
Hill Virginia
Atefi Mohammad
I. Schaffer Michael
Original Assignee
Psychemedics Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Psychemedics Corporation filed Critical Psychemedics Corporation
Publication of BRPI0911552A2 publication Critical patent/BRPI0911552A2/pt
Publication of BRPI0911552B1 publication Critical patent/BRPI0911552B1/pt
Publication of BRPI0911552B8 publication Critical patent/BRPI0911552B8/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/948—Sedatives, e.g. cannabinoids, barbiturates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9486—Analgesics, e.g. opiates, aspirine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2474/00—Immunochemical assays or immunoassays characterised by detection mode or means of detection
    • G01N2474/20—Immunohistochemistry assay

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)

Abstract

"métodos para determinar a presença de um analito de interesse, de uma pluralidade de analitos de interesse diferentes, e de pelo menos um membro de uma classe de drogas de interesse" composições e métodos para detectar a presença e/ou quantidade de um ou mais analitos, incluindo analitos tais como drogas de abuso, são fornecidos. as composições incluem dois ou mais analitos associados com uma fase sólida, por exemplo, uma partícula ou uma placa de reservatório múltiplo. as composições e métodos também permitem a determinação simultânea, em tandem ou serial da presença e/ou quantidade de dois ou mais analitos de interesse em uma amostra.
BRPI0911552A 2008-04-29 2009-04-29 métodos para determinar a presença de um analito de interesse, e de uma pluralidade de analitos de interesse diferentes, e, composição BRPI0911552B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4889208P 2008-04-29 2008-04-29
US61/048892 2008-04-29
PCT/US2009/042061 WO2009134855A1 (en) 2008-04-29 2009-04-29 Solid phase multi-analyte assay

Publications (3)

Publication Number Publication Date
BRPI0911552A2 true BRPI0911552A2 (pt) 2019-03-06
BRPI0911552B1 BRPI0911552B1 (pt) 2019-11-05
BRPI0911552B8 BRPI0911552B8 (pt) 2021-07-27

Family

ID=40802062

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0911552A BRPI0911552B8 (pt) 2008-04-29 2009-04-29 métodos para determinar a presença de um analito de interesse, e de uma pluralidade de analitos de interesse diferentes, e, composição

Country Status (10)

Country Link
US (1) US10539580B2 (pt)
EP (2) EP2281204B1 (pt)
JP (2) JP5564491B2 (pt)
CN (2) CN105675892A (pt)
BR (1) BRPI0911552B8 (pt)
CA (2) CA2723162C (pt)
ES (2) ES2452473T3 (pt)
HU (1) HUE028235T2 (pt)
PL (2) PL2623987T3 (pt)
WO (1) WO2009134855A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5564491B2 (ja) 2008-04-29 2014-07-30 サイケメディクス コーポレイション 固相多分析物アッセイ法
CN102323414B (zh) * 2011-06-07 2013-09-11 西安金域医学检验所有限公司 一种苯巴比妥均相酶免疫检测试剂盒及其制备方法
WO2014005065A1 (en) 2012-06-28 2014-01-03 Psychemedics Corporation Detection of analytes in hair wash samples
JP2015529199A (ja) 2012-08-21 2015-10-05 オルソ−クリニカル ダイアグノスティクス，インコーポレイティド パリペリドンハプテンに対する抗体及びその使用
US11340237B2 (en) 2016-09-16 2022-05-24 Takeda Pharmaceutical Company Limited Metabolite biomarkers for diseases associated with the contact activation system
CN109790313A (zh) * 2016-09-30 2019-05-21 简·探针公司 经等离子体处理的表面上的组合物

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US832917A (en) * 1906-02-26 1906-10-09 George A Macbeth Colored signal-lens.
US6949344B1 (en) 1987-12-28 2005-09-27 Psychemical Corporation Hair analysis method
US6582924B1 (en) * 1987-12-28 2003-06-24 Psychemedics Corporation Hair analysis method
US5466579A (en) * 1987-12-28 1995-11-14 Psychemedics Corporation Hair analysis method
US5324642A (en) * 1987-12-28 1994-06-28 Psychemedics Corporation Ligand assays of enzymatic hair digests
US6022693A (en) 1987-12-28 2000-02-08 Psychemedics Corporation Hair analysis method
US4956467A (en) * 1988-04-01 1990-09-11 American Cyanamid Company Nucleophilic tertiary organophosphines
JPH01276066A (ja) * 1988-04-28 1989-11-06 Mitsui Petrochem Ind Ltd 免疫検定法による低分子化合物の検出方法
JP2837921B2 (ja) 1990-05-22 1998-12-16 サイケメディクス コーポレイション 毛髪分析法
EP0467078B1 (en) 1990-07-18 1996-05-08 Abbott Laboratories An analyte-subtitute reagent for use in specific binding assay methods, devices and kits
US5712157A (en) 1994-12-20 1998-01-27 University Of Washington Methods and materials for the immunoassay of apolipoprotein(a) and lipoprotein(a)
DE19504198A1 (de) * 1995-02-09 1996-08-14 Behringwerke Ag Kompetitiver Immuntest unter Verwendung komplexierter Analytderivate
US6329566B1 (en) * 1997-05-29 2001-12-11 The General Hospital Corporation Methods for the detection, treatment, and prevention of neurodegeneration
US6231982B1 (en) 1997-12-10 2001-05-15 Dade Behring Inc. Particle reagents having reduced matrix effects and containing an aldehyde-reactive functional group
JP2002504689A (ja) 1998-02-18 2002-02-12 デイド・ベーリング・インコーポレイテッド 複数の検体の検出において使用するための化学ルミネセンス組成物
JPH11248703A (ja) * 1998-03-04 1999-09-17 Sanyo Chem Ind Ltd 遊離ハプテンの免疫学的測定法
GB2339615B (en) * 1998-07-14 2001-02-07 Cozart Bioscience Ltd Screening device and method of screening an immunoassay test
US7297554B2 (en) * 1998-11-18 2007-11-20 Microdiagnostics, Inc. Immunoassay system
JP4288750B2 (ja) * 1999-05-14 2009-07-01 日油株式会社 免疫学的測定方法
US6509196B1 (en) * 2000-01-04 2003-01-21 Response Biomedical Corp. Compensation for non-specific signals in quantitative immunoassays
EP1305632B1 (en) 2000-05-04 2011-07-27 Siemens Healthcare Diagnostics Products GmbH Methods for detection of multiple analytes
US7083925B2 (en) * 2002-01-11 2006-08-01 Schnabel Robert D Method of parentage testing in North American bison, Bison bison and domestic cattle using microsatellite loci
CA2478658C (en) * 2002-03-12 2011-10-18 Japan Science And Technology Agency Sandwich immunoassay kits for detecting ciguatoxin ctx3c
WO2003093511A1 (en) * 2002-04-30 2003-11-13 Merck & Co., Inc. Human papillomavirus multiplexed assay
US7195875B2 (en) * 2003-04-18 2007-03-27 Beckman Coulter, Inc. Oligonucleotide pairs for multiplexed binding assays
WO2005017485A2 (en) * 2003-05-22 2005-02-24 Agdia, Inc. Multiplex enzyme-linked immunosorbent assay for detecting multiple analytes
US7323346B2 (en) * 2003-08-14 2008-01-29 The General Hospital Corporation Screening for gestational disorders
US7413868B2 (en) * 2003-11-05 2008-08-19 Trellis Bioscience, Inc. Use of particulate labels in bioanalyte detection methods
CN1673745A (zh) * 2003-12-20 2005-09-28 苏冬梅 酶联免疫吸附elisa同步快速测定多项免疫指标的方法
WO2005072398A2 (en) * 2004-01-28 2005-08-11 Bamburgh Marrsh Llc Specimen sample collection device and test system
GB2404022B (en) * 2004-06-14 2005-08-10 Cozart Bioscience Ltd Competitive assays for the detection of methamphetamine group drugs
US20060166376A1 (en) 2005-01-21 2006-07-27 Craig Alan R Compositions for use as a signal generation component and methods of using same
US7629129B1 (en) * 2005-04-26 2009-12-08 The United States Of America As Represented By The Secretary Of The Army Hair follicle bulb as a biodosimeter
EP1880207A4 (en) * 2005-05-11 2010-09-08 Embrex Inc COMPETITIVE PARTICLE IMMUNOASSAY PROCESS USING FLUORESCENT MICROSCOPY
US7795040B2 (en) * 2006-04-17 2010-09-14 Luminex Corporation Methods, particles, and kits for determining activity of a kinase
CN1885038B (zh) * 2006-07-11 2010-08-18 华南农业大学 一种检测克伦特罗酶联免疫试剂盒及其检测方法与检测前动物组织的制样方法
CN101529251B (zh) * 2006-11-01 2014-04-02 贝克曼考尔特公司 用于亲合分析的结合性表面
US8084215B2 (en) 2008-04-29 2011-12-27 Psychemedics Corporation Non-proteolytic method for the determination of analytes in keratinized structures
JP5564491B2 (ja) 2008-04-29 2014-07-30 サイケメディクス コーポレイション 固相多分析物アッセイ法

Also Published As

Publication number Publication date
ES2562659T3 (es) 2016-03-07
BRPI0911552B1 (pt) 2019-11-05
CN105675892A (zh) 2016-06-15
US20110118138A1 (en) 2011-05-19
CA2943923C (en) 2018-02-06
CN102077094A (zh) 2011-05-25
HK1155221A1 (zh) 2012-05-11
EP2281204A1 (en) 2011-02-09
WO2009134855A1 (en) 2009-11-05
EP2623987A1 (en) 2013-08-07
HUE028235T2 (en) 2016-12-28
JP2014209123A (ja) 2014-11-06
JP5564491B2 (ja) 2014-07-30
BRPI0911552B8 (pt) 2021-07-27
JP5890864B2 (ja) 2016-03-22
ES2452473T3 (es) 2014-04-01
CA2723162C (en) 2016-11-01
JP2011519048A (ja) 2011-06-30
EP2281204B1 (en) 2014-01-08
CN102077094B (zh) 2016-03-09
PL2281204T3 (pl) 2014-06-30
EP2623987B1 (en) 2015-12-30
PL2623987T3 (pl) 2016-07-29
HK1186522A1 (en) 2014-03-14
CA2943923A1 (en) 2009-11-05
US10539580B2 (en) 2020-01-21
HK1154072A1 (en) 2012-04-13
CA2723162A1 (en) 2009-11-05

Similar Documents

Publication Publication Date Title
Raoof et al. Targeting FGFR overcomes EMT-mediated resistance in EGFR mutant non-small cell lung cancer
Zhang et al. Heparan sulfate assists SARS-CoV-2 in cell entry and can be targeted by approved drugs in vitro
Franzen et al. Senescence‐associated DNA methylation is stochastically acquired in subpopulations of mesenchymal stem cells
BRPI0911552A2 (pt) métodos para determinar a presença de um analito de interesse, de uma pluralidade de analitos de interesse diferentes, e de pelo menos um membro de uma classe de drogas de interesse.
Galetti et al. Effect of ABCG2/BCRP expression on efflux and uptake of gefitinib in NSCLC cell lines
Cheung et al. Preclinical efficacy of azacitidine and venetoclax for infant KMT2A-rearranged acute lymphoblastic leukemia reveals a new therapeutic strategy
GB2477053B (en) Droplet-based assay system
BR112014019168A8 (pt) Método capaz de detectar de forma não degenerada presença ou ausência de analitos em um único volume de amostra e método de detecção da presença ou ausência de cada analito dentre uma pluralidade de analitos
BRPI0911067B8 (pt) métodos e sistemas para determinar a presença ou ausência de um analito em uma amostra de líquido
BR112013002236A2 (pt) "substrato polimérico, métodos para fornecer um substrato polimérico, para fabricar um chip, e para analisar, detectar, separar e/ou transportar analitos, chip feito de dois substratos, kits para a fabricação de um chip e para a análise e/ou detecção e/ou separação e/ou transporte de analitos, e, uso de um substrato polimérico."
BRPI0911863A2 (pt) método para determinar a presença de um analito em uma amostra de estrutura queratinizada de um indivíduo.
WO2012024255A3 (en) Camkk-beta as a target for treating cancer
BR112014031365A2 (pt) métodos de detectar doenças ou condições
WO2005118806A3 (en) METHODS AND COMPOSITIONS INVOLVING MicroRNA
MX2013004305A (es) Metodos para determinar isotipos de anticuerpos anti-farmacos.
WO2012019200A3 (en) Assay systems for determination of source contribution in a sample
BR112014030298A2 (pt) ensaios multiplexados baseados em aptâmero
WO2010005531A3 (en) Methods for the detection of advanced glycation endproducts and markers for disease
Burchiel et al. Differential susceptibility of human peripheral blood T cells to suppression by environmental levels of sodium arsenite and monomethylarsonous acid
WO2007106507A3 (en) Detection of gene expression in mixed sample or tissue
WO2007114986A3 (en) Cooperative probes and methods of using them
EP3320900A3 (en) Marker for determination of sensitivity to anticancer agent
WO2010092164A3 (en) Bacterial dna as markers of cardiovascular and/or metabolic disease
EP2909628A4 (en) VOLUMETRIC MULTIPLEXED BALANCE DIAGRAM CHIP FOR BIOMARKERS AT THE TREATMENT PLACE AND / OR ANALYTIC QUANTIFICATION
WO2011008814A3 (en) Multiplexed measurement of exogenous and endogenous dna

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 05/11/2019, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 29/04/2009, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO